These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 26875861)

  • 1. Utility of folate receptor alpha immunohistochemistry in cytology specimens of metastatic breast carcinoma, metastatic serous carcinoma of Müllerian origin, and primary lung adenocarcinoma.
    Sheikh UN; Cohen C; Siddiqui MT
    Diagn Cytopathol; 2016 May; 44(5):369-76. PubMed ID: 26875861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folate Receptor Alpha Immunohistochemistry in Cytology Specimens of Metastatic Breast Carcinoma.
    Sheikh UN; Cohen C; Siddiqui MT
    Acta Cytol; 2015; 59(4):298-304. PubMed ID: 26413911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folate receptor α associated with triple-negative breast cancer and poor prognosis.
    Zhang Z; Wang J; Tacha DE; Li P; Bremer RE; Chen H; Wei B; Xiao X; Da J; Skinner K; Hicks DG; Bu H; Tang P
    Arch Pathol Lab Med; 2014 Jul; 138(7):890-5. PubMed ID: 24028341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folate Receptor α Expression Level Correlates With Histologic Grade in Lung Adenocarcinoma.
    Driver BR; Barrios R; Ge Y; Haque A; Tacha D; Cagle PT
    Arch Pathol Lab Med; 2016 Jul; 140(7):682-5. PubMed ID: 26599808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of immunohistochemical markers in primary lung and breast cancers enriched for triple-negative tumours.
    Provenzano E; Byrne DJ; Russell PA; Wright GM; Generali D; Fox SB
    Histopathology; 2016 Feb; 68(3):367-77. PubMed ID: 26118394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triple Negative Breast Cancer: Expression of Folate Receptor Alpha in Indian population.
    Gajaria P; Kadu V; Patil A; Desai S; Shet T
    Ann Diagn Pathol; 2020 Dec; 49():151598. PubMed ID: 32919338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of TRPS-1 immunohistochemistry in diagnosis of metastatic breast carcinoma in cytology specimens.
    Abdelwahed M; Yurtsever N; Savant D; Karam P; Gimenez C; Das K; Sheikh-Fayyaz S; Khutti S
    J Am Soc Cytopathol; 2022; 11(6):345-351. PubMed ID: 36055933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folate Receptor Alpha Expression Is Associated With Increased Risk of Recurrence in Triple-negative Breast Cancer.
    Ginter PS; McIntire PJ; Cui X; Irshaid L; Liu Y; Chen Z; Shin SJ
    Clin Breast Cancer; 2017 Nov; 17(7):544-549. PubMed ID: 28410844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reliability of Her2/neu, estrogen receptor, and progesterone receptor testing by immunohistochemistry on cell block of FNA and serous effusions from patients with primary and metastatic breast carcinoma.
    Shabaik A; Lin G; Peterson M; Hasteh F; Tipps A; Datnow B; Weidner N
    Diagn Cytopathol; 2011 May; 39(5):328-32. PubMed ID: 21488175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of GATA3 immunohistochemistry for diagnosis of metastatic breast carcinoma in cytology specimens.
    Braxton DR; Cohen C; Siddiqui MT
    Diagn Cytopathol; 2015 Apr; 43(4):271-7. PubMed ID: 25088841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of folate receptor-α (FRA) in gynecologic malignancies and its relationship to the tumor type.
    O'Shannessy DJ; Somers EB; Smale R; Fu YS
    Int J Gynecol Pathol; 2013 May; 32(3):258-68. PubMed ID: 23518909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folate receptor alpha (FRA) expression in breast cancer: identification of a new molecular subtype and association with triple negative disease.
    O'Shannessy DJ; Somers EB; Maltzman J; Smale R; Fu YS
    Springerplus; 2012; 1():22. PubMed ID: 23961352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgA Fc-folate conjugate activates and recruits neutrophils to directly target triple-negative breast cancer cells.
    Frontera ED; Khansa RM; Schalk DL; Leakan LE; Guerin-Edbauer TJ; Ratnam M; Gorski DH; Speyer CL
    Breast Cancer Res Treat; 2018 Dec; 172(3):551-560. PubMed ID: 30155754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The diagnostic utility of trichorhinophalangeal syndrome type 1 immunohistochemistry for metastatic breast carcinoma in effusion cytology specimens.
    Chen CJ; Hang JF; Chen YA; Lin SJ; Chiu HM; Hsu CY; Lai CR; Yang CS
    Cancer Cytopathol; 2023 Apr; 131(4):226-233. PubMed ID: 36399408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comprehensive analysis of GATA3 expression in carcinomas of various origins with emphasis on lung carcinomas.
    Bota EC; Koumoundourou D; Ravazoula P; Zolota V; Psachoulia C; Kardari M; Karampitsakos T; Tzouvelekis A; Tzelepi V; Sampsonas F
    Monaldi Arch Chest Dis; 2023 Aug; 94(2):. PubMed ID: 37667882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significantly increased PELP1 protein expression in primary and metastatic triple-negative breast carcinoma: comparison with GATA3 expression and PELP1's potential role in triple-negative breast carcinoma.
    Dang DN; Raj G; Sarode V; Molberg KH; Vadlamudi RK; Peng Y
    Hum Pathol; 2015 Dec; 46(12):1829-35. PubMed ID: 26428280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Young investigator challenge: The utility of GATA3 immunohistochemistry in the evaluation of metastatic breast carcinomas in malignant effusions.
    Lew M; Pang JC; Jing X; Fields KL; Roh MH
    Cancer Cytopathol; 2015 Oct; 123(10):576-81. PubMed ID: 26465236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GATA-3 and FOXA1 expression is useful to differentiate breast carcinoma from other carcinomas.
    Davis DG; Siddiqui MT; Oprea-Ilies G; Stevens K; Osunkoya AO; Cohen C; Li XB
    Hum Pathol; 2016 Jan; 47(1):26-31. PubMed ID: 26527523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pax8: a marker for carcinoma of Müllerian origin in serous effusions.
    Tong GX; Devaraj K; Hamele-Bena D; Yu WM; Turk A; Chen X; Wright JD; Greenebaum E
    Diagn Cytopathol; 2011 Aug; 39(8):567-74. PubMed ID: 20607683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folate receptor in adenocarcinoma and squamous cell carcinoma of the lung: potential target for folate-linked therapeutic agents.
    Cagle PT; Zhai QJ; Murphy L; Low PS
    Arch Pathol Lab Med; 2013 Feb; 137(2):241-4. PubMed ID: 22984810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.